• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Advisory Committees

  • Print
  • Share
  • E-mail

Slides for the March 31, 2009 Meeting of the Oncologic Drugs Advisory Committee

FDA

Sandra Casak, M.D., Staff Fellow, Division of Biologic Oncology Products (DBOP), OODP, OND, CDER, FDA [PDF]

Lee Pai-Scherf, M.D., Medical Officer, Division of Biologic Oncology Products (DBOP), OODP, OND, CDER, FDA

Yuan Li Shen, Dr. P.H., Statistical Reviewr-Biologic Oncology, Division of Biostatisitics 5 (DB5), Office of Biostatistics ( OB ), Office of Translational Science (OTS), CDER, FDA [PDF]

Guest Speaker Presentation

Victor Levin, M.D., Professor and Bernard W. Biedenharn Chair for Cancer Research, Department of Neuro-Oncology, The University of Texas MD Anderson Cancer Center [PDF]

Sponsor

Genentech, Inc. [PDF]

Open Public Hearing

OPH #1 [PDF]